
MAHA COMMISSION CALLS FOR HEALTH OVERHAUL
The Highwire with Del Bigtree
00:00
Reforming Pharmaceutical Advertising Regulations
This chapter explores a new executive order aimed at reinstating pre-1997 regulations for pharmaceutical advertising, focusing on the impact of such changes on public health and the media landscape. It critiques the influence of pharma funding on journalism and discusses the implications of requiring full side effect disclosure in TV ads.
Transcript
Play full episode